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Abstract
Protein engineering of microbial rhodopsins has been successful in generating variants with 
improved properties for applications in optogenetics. Members of this membrane protein family 
can act as both actuators and sensors of neuronal activity. Chimeragenesis, structure-guided 
mutagenesis, and directed evolution have proven effective strategies for tuning absorption 
wavelength, altering ion specificity and increasing fluorescence. These approaches facilitate the 
development of useful optogenetic tools and, in some cases, have yielded insights into rhodopsin 
structure-function relationships.
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Introduction
Optogenetics refers to the ability to control or monitor cellular activities with light (‘opto’) 
using genetically encoded machinery (‘genetics’). For nearly a decade, a major focus has 
been neuroscience. Light-activated microbial rhodopsins can be transgenically expressed in 
neurons to reversibly control and sense neural activity with relevant speed and precision [1]. 
Coupling targeted perturbations stimulated by light to specific readouts (e.g., behavioral 
phenotypes or electrical recordings) enables the functional dissection of neural circuits [2-4]. 
Certain rhodopsins can also function as fluorescent voltage indicators providing optical 
detection of neuronal activity (and perhaps other electrically active cell types) [5-7]. 
Unfortunately, rhodopsins have broad activation spectra, making multiplexed control of 
*
 To whom correspondence should be addressed. frances@cheme.caltech.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Curr Opin Struct Biol. Author manuscript; available in PMC 2016 August 01.
Published in final edited form as:
Curr Opin Struct Biol. 2015 August ; 33: 8–15. doi:10.1016/j.sbi.2015.05.001.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
cells with various light colors challenging, and current fluorescent variants are extremely 
dim, which limits the scope of a potential “all-optical electrophysiology” [8-11]. 
Overcoming these challenges by improving rhodopsin-based tools has and will continue to 
require various elements of protein engineering. In this review, we present examples of how 
protein engineering has enhanced specific rhodopsin functions for applications in 
optogenetics. Specifically, we describe how rhodopsin actuators and sensors have been 
engineered and what limitations remain.
Rhodopsins are a family of light-activated integral membrane proteins that adopt a seven 
trans-membrane α-helical fold referred to as the G protein-coupled receptor fold. The 
polyene chromophore retinal is covalently attached to the ε-amino group of a conserved 
lysine residue on the seventh α-helix through a protonated Schiff base (PSB) linkage [12]. In 
microbes, rhodopsins can act as receptors that change conformation in response to light to 
trigger intracellular signaling, as pumps that drive protons or chloride ions across the cell 
membrane, or as non-specific cation channels [13].
Microbial rhodopsin pumps and channels are widely used for optogenetic applications. 
Light-triggered isomerization of retinal from all-trans to 13-cis initiates the rhodopsin 
photocycle and ultimately results in the movement of ions across the membrane [12]. When 
transgenically expressed in neurons, channelrhodopsins (ChRs) mediate light-dependent 
transport of cations into the cell, causing depolarization and stimulation of action potentials 
[1,14-17]. In contrast to the excitatory ChRs, both proton- and chloride-pumping rhodopsins 
can be used to selectively hyperpolarize the cell and inhibit action potentials through either 
pumping protons out or pumping chloride into the cell [1,18]. Collectively, these tools 
facilitate genetically targeted, reversible loss and gain of function experiments in vivo. Since 
these proteins allow light-dependent ‘actuation’ of neuronal activity, we refer to them as 
actuators (Figure 1, Table 1).
Over the past few years, several proton-pumping rhodopsins have been identified that 
exhibit weak fluorescence that is sensitive to changes in the local electronic environment 
(e.g., changes in pH and trans-membrane voltage) [5-7]. One proton pumping rhodopsin, 
Archaerhodopsin-3 (Arch) from Halorubrum sodomense, has been extensively characterized 
in mammalian neurons for both light-activated proton pumping and voltage sensitive 
fluorescence [5,8,9,19]. Wild-type Arch transports protons in response to light used to excite 
opsin fluorescence (635 – 655 nm). This activity can be attenuated or eliminated by 
introducing mutations at residues known to be critical for pumping [5,8,9,19], thereby 
creating a tool for voltage sensing independent of hyperpolarization. We refer to these 
rhodopsin variants as sensors (Figure 1, Table 2).
Spectral Tuning of Microbial Rhodopsins
Microbial rhodospsin actuators from nature are optimally activated by light in the range of 
450 – 570 nm. The absorption maximum of rhodopsin is determined by the energy gap 
between the resting state (S0) and excited state (S1) of the retinal chromophore. Narrowing 
or increasing the S0-S1 energy gap results in blue or red shifts, respectively. Stabilization of 
these states is governed by interactions between the protein and retinal, which itself is 
surrounded by a hydrophobic binding pocket with five conserved aromatic residues in 
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transmembrane helix 3, 5, 6, and 7 [20]. Experimental and theoretical work suggest that the 
amino acids surrounding retinal affect the S0-S1 energy gap by altering the polarity of the 
retinal binding cavity [21-23] and the distance between the Schiff base linkage to retinal and 
its counter-ion [24-26].
For optogenetics, identifying variants with well-separated absorption spectra is of great 
interest for multiplexed control of excitation and inhibition by different colors of light in a 
single cell or in a population of cells. Lin et al. reported a variant called ReaChR that is 
optimally excited by orange-red light with λmax in the range 590 – 630 nm [27]. ReaChR is 
an engineered chimeric variant of VChR1, a cation-conducting ChR from Volvo carteri, 
which is maximally excited at 589 nm [27,28]. ReaChR has helix 6 replaced with that of 
VChR2 (also from Volvo carteri), which improves protein expression, and has the sequence 
of ChR1 from Chlamydamonas reinhardtii at the N-terminus, which further improves 
plasma membrane localization. To further improve the chimera's properties a number of 
single amino acid mutations were tested based on mutations that had previously been shown 
to alter ChR properties. One such single amino acid mutation (L171I) increased the 
amplitude of the photoresponse at 610 nm and 630 nm [27]. The L171 position was 
previously mutated in the ChR chimera ChEF [29] and was targeted because of its position 
proximal to the retinal binding pocket. ReaChR demonstrates that transferring mutations or 
even parts of domains between variants can confer desired properties (i.e., improved 
photostability and membrane localization). More broadly, chimeragenesis has proven to be a 
good engineering strategy to achieve spectral shifts in ChRs: in an earlier study from Prigge 
et al., helix swapping between ChR1, ChR2, VChR1, and VChR2 resulted in variants with 
red- and blue-shifted spectra, though none as red-shifted as ReaChR [30].
Spectral tuning of ChRs using higher throughput approaches has remained a challenge in 
part due to limited ChR expression in Escherichia coli, a common host for directed 
evolution [31,32]. The presence of predicted N-glycosylation sites in several rhodopsins 
suggests that glycosylation, which E. coli does not naturally perform, is required for 
functional ChR expression [32]. If the lack of glycosylation is limiting expression, then 
expressing ChRs in E. coli with a re-constituted eukaryotic glycosylation pathway (which 
was recently reported in [33]) may be possible. ChRs can be expressed in Pichia pastoris 
[34], suggesting that directed evolution should be possible in this system or in laboratory 
yeasts such as Saccharomyces cerevisiae.
In contrast to ChRs, proton-pumping rhodopsins (PPRs) can typically be expressed in E. 
coli. Recently, spectral tuning of a PPR from Gloeobacter violaceus called GR was 
performed by directed evolution in moderate-throughput (2,000 variants/round of screening) 
using E. coli to express the variants [23*]. Site-saturation mutagenesis at 19 positions 
around the retinal chromophore followed by recombination of beneficial mutations and 
further site-saturation mutagenesis generated large spectral shifts in absorption spectra 
relative to wildtype GR. Collectively, variants with shifts of +/− 80 nm compared to 
wildtype GR were achieved. The large shifts, however, came at the cost of proton pumping 
capacity [23*]. Further characterization of evolved variants revealed that blue-tuning 
mutations modulate the polarity along the retinal chromophore. Blue-tuning mutations near 
the PSB generally increased polarity relative to the native residues, while blue-tuning 
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mutations near the beta-ionone ring decreased polarity [23*], consistent with recent 
theoretical predictions [35]. In contrast, red-tuning mutations occurred near the PSB linkage 
to retinal and likely disrupted its interaction with the negatively charged counter-ion [23*]. 
While directed evolution is clearly an effective strategy for spectral tuning, identifying 
variants with large shifts in absorbance and wildtype activity levels remains a challenge that 
the screening methods used to date have not been able to address.
Engineering Rhodopsin Ion Selectivity
Currently, inward-pumping chloride-transporting rhodopsins and outward-pumping proton-
transporting rhodopsins are widely used for inhibiting neurons [1]. Rhodopsin channels 
(ChRs) can transport many ions for every photon of absorbed light, while pumps can only 
move a single ion per photon. Increased efficiency of ion translocation enables targeted 
perturbations with less light (often advantageous for optogenetics applications) but comes at 
the cost of transient perturbations of membrane conductance. Engineering potassium- and 
chloride-selective ChRs would enable selective inhibition in a way that better mimics 
natural neuronal physiology, with decreased photon flux. While ChRs’ non-specific influx 
of cations can effectively stimulate neuronal activity, enhanced selectivity for calcium could 
enable direct control of a number of cellular processes dependent on intracellular calcium 
ions (e.g., muscle contraction, release of neurotransmitters from nerve terminals, and gene 
expression). Ion-specific rhodopsins would be invaluable tools for studying downstream 
physiological responses to specific ions/second messengers both in neuroscience and 
beyond.
Recently, two groups independently engineered ChR chloride channels that can silence 
neurons [36**,37] with the aid of the dark state crystal structure of the ChR variant, C1C2 (a 
chimera of ChR1 and ChR2) [20] (Figure 2). Berndt et al. speculated that since the ion-
selectivity pore in C1C2 is less ordered than that in potassium-selective channels [38-40], 
natural cation-specific activity is driven by the electrostatic potential surrounding the C1C2 
pore and vestibule [36**]. By identifying single amino acid mutations in this region that 
modified the channel reversal potential and combining the single mutations into a variant 
called inhibitory C1C2 (iC1C2), they created a chloride-specific channel that can silence 
action potentials in response to light [36]. Wietek et al. took a different approach: using 
molecular dynamics simulations, they identified 5 residues that form a hydrophobic barrier 
in darkness to prevent water from entering the protein vestibule [37]. One of these residues, 
E90, when mutated to lysine or arginine, decreased ChR2's reversal potential and turned 
ChR2 into a light-activated chloride channel at membrane holding potentials above about 
−40 mV. Introduction of the T159C mutation improved membrane targeting of the protein in 
mammalian cells [37]. The resulting variant, ChloC, required two mutations to transform 
ChR2 into an effective tool for silencing action potentials in neurons in the presence of light 
[37].
Ideally the inhibitory channels would have a decelerated channel closure, which would 
enable a prolonged ion-conducting state with a brief light stimulation. This has been 
achieved for the excitatory channel, ChR2, by introduction of a mutation at C128 which 
significantly decreased the time for channel closure once light is turned off (off kinetics, 
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τoff) of the ChR2 parent [41]. The C128 mutation was introduced into ChR2 by analogy to 
previous work done with bacteriorhodopsin (bR), a light-driven proton pump, showing that 
the equivalent position in bR, when mutated, affects kinetics of the photocycle and lifetimes 
of intermediates [42,43]. The C128 residue is within 4 Å of the 12th carbon of retinal and, 
based on the C1C2 crystal structure [20], the thiol group is associated with the π-electron 
system in the retinal molecule [20]. Berndt et al. applied the equivalent mutation in iC1C2, 
which resulted in an inhibitory channel with slower channel closure that was named 
SwiChRCT. Wietek et al. engineered a slow-closing version of the inhibitory channel ChloC 
with mutations at position D156, a residue thought to interact with C128 [37].
Exploring Natural Variants for New Rhodopsin Actuators
Combining protein engineering with environmental sample mining via de novo 
transcriptome sequencing has led to the identification of dozens of new rhodopsins [44,45]. 
Two new valuable ChRs recently identified, Chronos (activated with low intensity blue 
light) and Chrimson (activated with red light), together enable wavelength specific 
multiplexed perturbations of neurons [45]. A single mutation, K176R (which was previously 
shown to enhance photocurrents at the equivalent position in ChR2 [46]), was introduced 
into Chrimson to improve its slow kinetics to generate ChrimsonR [45]. Screening members 
of the cruxhalorhodopsin family led to identification of Halo57 from H. salinarum [44]. 
Introducing two single mutations into Halo57 to boost photocurrents and appending 
trafficking sequences from [47] resulted in an optimized variant called Jaws, a red-shifted 
inhibitor of neuronal activity [44]. A major limitation in synchronous sensing and perturbing 
of neuronal activity for all-optical electrophysiology is that the light used to activate the 
actuator can perturb the fluorescence readout of the sensor. A highly light-sensitive, blue-
shifted channelrhodopsin variant (sdChR, [45**]) identified in a screen of plant genomes 
was further engineered for faster kinetics and improved membrane localization to produce 
CheRiff to enable subcellular excitation [9] (Figure 3).
Engineering of Rhodopsin Voltage Indicators
Adam Cohen and colleagues recently discovered that rhodopsins can be used as genetically 
encoded voltage indicators (GEVIs); however, the natural proteins suffer from extremely 
low quantum efficiencies (~10−4) [5]. Eliminating pumping activity while retaining fast 
kinetics also presents an engineering challenge since the relationship between pumping, 
fluorescence, and kinetics is not completely understood. The photocycle of Arch, a leading 
candidate for GEVI development, is thought to proceed as follows: absorption of a photon 
initiates the photocycle (g → M), leading to an equilibrium between the M state (protonated 
counter-ion) and N state (protonated Schiff base) [48]. Following conversion of N → Q 
(through absorption of photon at 540 nm) and excitation of the Q-state (absorption of photon 
at 570 nm), a photon at 710 is emitted as fluorescence as Arch returns to the N intermediate 
[48]. Retinal thermally isomerizes back to all-trans (N → O) and a proton is released at the 
extracellular side (O → g). Based on this model, mutants with a longer-lived Q-state should 
exhibit increased fluorescence.
Directed evolution is an effective strategy for enhancing the brightness of Arch [9,49,50]. 
For example, introduction of mutations near the lysine that forms the covalent Schiff base 
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linkage to retinal and screening for fluorescence enabled identification of two variants of 
Arch, one a double mutant, D95E/T99C (Archer) and another containing 5 mutations 
(referred to as QuasAr1). Both Archer and QuasAr1 show enhanced voltage sensitive 
fluorescence with emission in the far-red (maximal emission > 680 nm) [8,9,49]. Both of 
these engineered variants have improved brightness and dynamic range compared to two 
previously published variants, Arch EEQ and Arch EEN [19].
Directed evolution of Archer revealed two fluorescence enhancing mutations, V59A and 
I129T [49], that were independently identified at the homologous positions in bR (V49A 
and I119T) and shown to stabilize the Q-state intermediate [51]. Many mutations at P60 
(<5Å from retinal) also increase Arch fluorescence [49]; similarly, many mutations at the 
homologous bR position (P50) stabilized the Q state [51]. These observations are consistent 
with the Q state being the fluorescent state in the Arch photocycle [48].
Since their absorbance is sensitive to changes in electric potential [52], rhodopsins can also 
potentially be used in FRET sensors, assuming the absorbance overlaps with the emission of 
a bright fluorescent protein. Recently, a FRET-opsin sensor (a fusion between L. maculans 
[Mac] rhodopsin and mOrange2 [a monomeric orange fluorescent protein [53]]) was 
developed, achieving a response time of ~5 ms following a step change in membrane 
voltage and successful detection of sub-threshold events [7]. To eliminate Mac pumping, the 
PSB counter-ion D139 was replaced with glutamine (Q). While replacing the counter-ion 
with a neutral residue is a general strategy for eliminating pumping, the D139N variant 
retained sufficient pumping activity to perturb neural spiking patterns; thus, D139Q or its 
equivalent is the preferred mutation for Mac-based sensors [7]. However, current Mac-
mOrange2 derivatives have a lower dynamic range (defined as voltage-dependent changes 
with respect to the probe's baseline fluorescence) than recently engineered Arch variants 
[8,9,49]. Using an expression vector that can drive expression in both prokaryotic and 
eukaryotic cells, Zou et al. developed a screening strategy in which brighter Arch-mOrange2 
variants can be identified in E. coli and subsequently transfected into HEK293 cells to 
measure their voltage sensitivity [50*]. This engineering strategy accelerates the speed at 
which brighter, multi-colored, and voltage-sensitive rhodopsins can be identified and has 
resulted in FRET sensors with rise times in the range 1 – 7 ms [50*].
Engineered rhodopsin-based sensors are still quite dim, with quantum yields of <1%. 
Alternative voltage sensors have been engineered by fusing the Ciona intestinalis voltage-
sensor containing domain (Ci-VSD), a non-rhodopsin protein that undergoes a voltage-
dependent conformational change, to a fluorescent protein [54]. The issue of slow kinetics of 
these non-rhodopsin sensors [55] has been largely overcome [56], but they exhibit non-
linear voltage sensitivity, which may limit their capacity for detecting sub-threshold events 
[56]. Despite being fused to bright fluorescent proteins and increased basal fluorescence 
over rhodopsins, the spectral overlap between Ci-VSD-based sensors and rhodopsins limits 
their compatibility for all-optical electrophysiology (Figure 3); furthermore, rhodopsins 
appear to be less susceptible to photo-bleaching [8].
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Conclusion
Rhodopsins are powerful tools for brain research. Identifying actuators with shifted and 
narrowed spectra would improve the ability to multiplex perturbations with different colors 
of light, whereas enhancing ion specificity will enable more physiological studies within and 
beyond neuroscience. Brighter rhodopsin sensors have been engineered, but further 
improved brightness would facilitate imaging populations of neurons (and perhaps other 
electrically-active cell-types such as cardiomyocytes) with wide-field microscopy. The 
development of opsin-FRET sensors could also enable monitoring different cell types with 
different colors of light [50], a potentially powerful application of all-optical 
electrophysiology. Future work would greatly benefit from an understanding of how 
characterized mutations impact the photocycle and the protein structure and thereby 
contribute to the desirable properties found in engineered rhodopsins. Chimeragenesis, 
structure-guided mutagenesis, and directed evolution have and will continue to play central 
roles in the development of improved rhodopsins for optogenetics.
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Abbrevations
Arch Archaerhodopsin-3
bR bacteriorhodopsin
ChR Channelrhodopsin
ChR1 Chlamydomonas reinhardtii channelrhodopsin-1
ChR2 Chlamydomonas reinhardtii channelrhodopsin-2
C1C2 chimera of ChR1 and ChR2
GEVI genetically encoded voltage indicator
HEK293 cells human embryonic kidney 293 cells
FRET Förster resonance energy transfer
GR Gloeobacter violaceus rhodopsin
PPR proton-pumping rhodopsin
PSB protonated Schiff base
sdChR Scherffelia dubia channelrhodopsin
VChR1 Volvox carteri channelrhodopsin-1
VChR2 Volvox carteri channelrhodopsin-2
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Highlights
• Rhodopsins are useful sensors and actuators of neuronal activity.
• Bifunctional rhodopsin constructs facilitate all-optical electrophysiology.
• Protein engineering can enhance rhodopsin properties for optogenetics.
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Figure 1. Rhodopsins can be used as actuators and sensors in optogenetics
Actuators transport ions across the membrane to activate or repress neuronal activity. ChRs 
transport positively charged ions into the cell, while proton-pumping rhodopsins (PPRs) 
move protons out of the cell. In the ideal case, engineered rhodopsin sensors emit light as 
fluorescence in the farred in a voltage-dependent fashion.
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Figure 2. Residues that affect ion selectivity in the channelrhodopsin C1C2
The illustration shows crystal structure of C1C2, with putative ion gating residues S102, 
E129 and N297 highlighted in green. Mutation of the gating residue N297 to D results in a 
significant increase in selectivity for Ca2+, while mutation of E129 to Q or A results in a 
significant decrease in the channel's Ca2+ selectivity [20]. Mutating the highly conserved 
gating residue E129 [45] has significant effects on the channel's selectivity for Cl− in both 
the C1C2 backbone and the ChR2 backbone (position E90 in the ChR2 backbone) [36,37]. 
Mutation of E90 in ChR2 to R or K increases the reversal potential as a result of increased 
Cl− selectivity to generate a light activated inhibitory channel [37]. Residues outside of the 
putative ion gate also influence channel selectivity (residues highlighted in purple). 
Mutations Q95A, E162 and D292A have all been shown to enhance H+ selectivity. Mutants 
K132A and Q95A display increased K+ permeability in the C1C2 backbone [20].
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Figure 3. Bifunctional constructs for all-optical electrophysiology
Archer, an engineered Archaerhodopsin-3 variant, enables optical monitoring of voltage 
with red light, and perturbation of membrane potential with blue light (left) [8]. 
Alternatively, one rhodopsin can be used for sensing with red light, while an engineered 
ChR can be used for perturbing the membrane with blue light (right) [9].
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